Full-Time

Team Lead – Government Pricing

Updated on 9/3/2026

MediSpend

MediSpend

51-200 employees

Life sciences compliance software and services

Compensation Overview

$75k - $90k/yr

+ Bonus

Remote in USA

Remote

Remote within the United States, with limited occasional travel for team meetings, training, or business events.

Bachelor's

Category
Risk & Compliance (1)
Required Skills
Data Analysis
Excel/Numbers/Sheets

Get referred to MediSpend

See people who can refer or advise you

Requirements
  • A bachelor's degree in Finance, Accounting, Business, Economics, Healthcare Administration, or a related field is required.
  • At least 3 years of pharmaceutical Government Pricing experience is required.
  • At least 1–3 years of team leadership, supervisory, or mentoring experience is required.
  • Strong working knowledge of pharmaceutical government pricing regulations and methodologies is required.
  • Experience with government pricing platforms such as iContracts, Model N, IntegriChain, EVERSANA, or comparable solutions, including transaction classification, calculation review, reconciliation, and reporting workflows, is required.
  • Advanced Microsoft Excel skills, including pivot tables, complex formulas, and data analysis, are required.
  • Strong analytical and problem-solving abilities are required.
  • Excellent organizational and project management skills are required.
  • Outstanding written and verbal communication skills are required.
  • Ability to manage multiple priorities in a deadline-driven environment is required.
  • Strong attention to detail with a commitment to quality and compliance is required.
Responsibilities
  • Lead, coach, and mentor a team of Government Pricing Analysts to ensure high-quality work and professional development.
  • Oversee daily team workload, prioritize assignments, and monitor deliverables to meet client and regulatory deadlines.
  • Coordinate daily team workload, prioritize assignments, and monitor deliverables to meet client and regulatory deadlines.
  • Provide hands-on technical expertise in Federal Drug Programs, including Average Manufacturer Price and Best Price.
  • Maintain working knowledge of Average Sales Price, Non-Federal Average Manufacturer Price, Federal Ceiling Price, and TRICARE rebates.
  • Review, validate, and approve government pricing calculations and reconciliations for client transactions.
  • Review and approve variance analyses, reporting packages, and supporting documentation before client delivery.
  • Ensure accurate and timely submission of all government pricing reports.
  • Assist with escalations for technical government pricing questions and calculation discrepancies.
  • Partner with clients to address questions, communicate results, and provide recommendations.
  • Coordinate team deliverable checklists and ensure adherence to internal controls and quality standards.
  • Develop, document, and improve standard operating procedures and best practices.
  • Identify opportunities for automation and continuous process improvement.
  • Support onboarding and training of new team members.
  • Collaborate with Finance, Compliance, Information Technology, and Client Success departments.
  • Assist the Government Pricing Manager with strategic initiatives, resource planning, performance management, and special projects.
Desired Qualifications
  • Experience leading client-facing government pricing engagements.
  • Experience with process improvement initiatives and workflow optimization.
  • Knowledge of Centers for Medicare & Medicaid Services, Medicaid, Veterans Affairs/Federal Supply Schedule, and other federal pricing regulations.
  • Experience developing standard operating procedures, training materials, and quality review processes.

MediSpend provides compliance solutions for the life sciences industry, offering software and advisory services to pharmaceutical, medical device, dental, and biotech companies worldwide. The software acts as a system of record for managing global healthcare regulations, while the advisory services help clients interpret rules and tailor controls. Unlike firms that only offer software or only consulting, MediSpend combines a cloud platform with professional guidance to help organizations stay compliant and reduce risk. The company’s goal is to enable life sciences companies to operate in line with global standards and healthcare laws, by proactively managing compliance risk and simplifying regulatory obligations.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Portsmouth, New Hampshire

Founded

2011

Get referred to MediSpend

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • More than 400 life sciences companies used MediSpend by March 2026.
  • The merger expanded coverage across compliance, medical affairs, field enablement, and revenue management.
  • AI-enabled Alucio acquisition and stewardshipNOW launch broadened cross-sell opportunities in 2025.

What critics are saying

  • Integration after the January 2026 merger threatens product focus and customer retention.
  • Revenue management bets intensify competition against Veeva, Oracle, and niche compliance vendors.
  • No disclosed funding, layoffs, or profitability data leaves existential execution risk unpriced.

What makes MediSpend unique

  • January 2026 merger united MediSpend and RLDatix Life Sciences into one platform.
  • March 2026 iContracts relaunch deepened revenue management across contract-to-cash workflows.
  • May 2025 Baker Tilly stewardshipNOW used MediSpend for external funding compliance.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Remote Work Options

Unlimited Paid Time Off

Paid Holidays

Paid Sick Leave

401(k) Company Match

401(k) Retirement Plan

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Company News

MediSpend
May 26th, 2026
Medispend expands Revenue Management leadership with addition of Chanan Greenberg.

Medispend expands Revenue Management leadership with addition of Chanan Greenberg. * 26 May 2026 Medispend is excited to welcome Chanan Greenberg as General Manager of Revenue Management Solutions, further strengthening the company's investment in helping life sciences organizations navigate the growing complexity of commercialization, pricing, and market access. As the life sciences industry continues to evolve, Revenue Management has become increasingly critical to operational success. Organizations are facing mounting pressure to manage pricing strategies, contracting, rebates, government programs, and compliance requirements with greater accuracy, visibility, and efficiency. Medispend's continued growth in this area reflects both the needs of the market and the company's long-term commitment to delivering innovative, connected solutions that support customers across the commercialization lifecycle. Chanan joins Medispend with extensive industry experience and a strong track record of leadership, strategic growth, and operational execution. In his role, he will lead the continued expansion and advancement of Medispend's Revenue Management Solutions business, working closely with customers and teams across the organization to drive innovation and deliver meaningful value to the market. "Revenue Management is a strategic growth area for Medispend, and we're thrilled to welcome Chanan to the team," said Chris Gingras, President. "His leadership experience, industry knowledge, and customer-first mindset make him an excellent fit as we continue expanding our capabilities and supporting the evolving needs of life sciences organizations." Chanan's addition comes at an important time as Medispend continues investing in technology and expertise that help customers simplify complexity, improve operational performance, and adapt to an increasingly dynamic healthcare landscape. "I'm excited to join Medispend and be part of a company that is deeply focused on innovation and customer success," said Greenberg. "There is tremendous opportunity ahead in Revenue Management, and I look forward to working with the team to help organizations navigate challenges, drive efficiency, and support better business outcomes." The addition of Chanan reflects Medispend's broader commitment to building industry-leading solutions and leadership teams that empower life sciences organizations to operate more strategically, compliantly, and effectively. Life sciences companies don't struggle with strategy, they struggle with executing that strategy at scale. Across Compliance, Medical Affairs, Commercial, Finance, and IT, a consistent Federal contracting expectations are changing, again. And this time, the implications for pharmaceutical manufacturers participating in VA and Federal Supply Schedule (FSS) contracting are significant. Coaching has long been a cornerstone of leadership in life sciences organizations, especially across sales teams. But as roles grow more complex, expectations increase, and Contact MediSpend Ready to grow your business compliantly? MediSpend is happy to answer any questions you may have and help you determine which of its solutions and services best fit your needs. Why Medispend: * Life Sciences Focused * End-to-End Solutions * Regulatory Expertise * Enterprise Scalability * Advanced Analytics * Trusted Partnership What happens next? Contact MediSpend. Medispend uses the contact information you provide to MediSpend to contact you about its products and services. You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as its privacy practices and commitment to protecting your privacy, check out its Privacy Policy.

Healthcare IT Today
Oct 3rd, 2025
MediSpend Merges with RLDatix Subsidiary

MediSpend and RLDatix Life Sciences have merged to form a leading global provider of regulatory and compliance SaaS solutions for the life sciences industry. The new company offers comprehensive software, data, and workflow tools for pharmaceutical, biotech, and medical device companies, serving over 300 clients worldwide. Supported by Five Arrows, Susquehanna Growth Equity, TA Associates, and Nordic Capital, the merger combines expertise in compliance, transparency, and sales enablement.

TA
Sep 11th, 2025
MediSpend Merges with RLDatix Life Sciences

MediSpend and RLDatix Life Sciences have merged to form a leading global provider of regulatory and compliance SaaS solutions for the life sciences industry. The new company, backed by Five Arrows, Susquehanna Growth Equity, TA Associates, and Nordic Capital, serves over 300 companies worldwide. It combines MediSpend's technology with RLDatix's expertise to enhance compliance, transparency, and sales enablement across the pharmaceutical, biotech, and medical device sectors.

Finanzen.net
Sep 2nd, 2025
MediSpend Merges with RLDatix Life Sciences

MediSpend and RLDatix Life Sciences have merged to form a leading global provider of regulatory and compliance SaaS solutions for the life sciences industry. The new company, backed by Five Arrows, Susquehanna Growth Equity, TA Associates, and Nordic Capital, serves over 300 companies worldwide. The merger aims to enhance innovation, compliance, and operational efficiency. The company will operate under both brand names initially, with plans to unify under a new name soon.

PR Newswire
Sep 2nd, 2025
MediSpend and Life Sciences Subsidiary of RLDatix Merge to Form Leading Global Provider of Regulatory and Compliance SaaS Solutions for Life Sciences

/PRNewswire/ -- MediSpend and RLDatix Life Sciences, a subsidiary of RLDatix, today announced a definitive agreement to merge, creating a new unified company...